Skip to content
★ Sign in to follow
BioPorto A/S logo

BioPorto A/S Stock: price and insider trades · Denmark

ISIN DK0011048619DK·Mcap DKK 514.9MHealth Care

No insider purchase over the last 90 days. The latest, by Thomas Magnussen, was filed 10 Aug 2017.

BioPorto A/S: what insiders have been doing

BioPorto A/S, classified in the Health Care sector, is a listed company based in Hellerup, Denmark, founded in 1917. Its insiders report their share dealings to Finanstilsynet DK. Between 31 October 2025 and 31 October 2026, 1 insider published 1 filing.

The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

With 1 filing in twelve months, the company is quieter than the median of 5 filings across the 73 companies we follow on the same exchange. Looking back to 2007, when coverage begins, insiders filed 2 purchases and 2 sales.

Over the last twelve months, not one insider purchase of BioPorto A/S stock was filed.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and UCB. This summary is built from Finanstilsynet DK disclosures alone and does not predict where the share price will go.

Key facts

Headquarters: Hellerup, Denmark · Founded: 1917

Source: Wikidata (CC0).

Insider Decl.
39
Thresholds
n/a
Buy Volume
€4M
2 ops. · all time
Sell Volume
€6M
2 ops. · all time

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 21,205 of 26,897 companies
31.6
score / 100
Value
13
Quality
50
FCF yld-15%
Earn yld-16%
EV/EBITDA·
ROE-26%
Gross mgn75%
Net mgn·
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

DKK 1.04
Analyst consensus
1 analysts
0.00/5
DKK 1.75Target DKK 1.75(+68%)DKK 1.75
Income statement
RevenueDKK 40.3M
Gross profitDKK 30.4M75% margin
EBITDA-DKK 84.6M-210% margin
Net income-DKK 82.1M-46.8% margin
Valuation
PER (forward)-17.3x
P/Book6.3x
Beta1.35
Balance sheet & cash
Market capDKK 514.9M
Total debtDKK 7.5M
Free Cash Flow-DKK 77.1M
Debt / Equity7%
Profitability & ownership
ROE-25.7%
ROA-8.7%
% insiders29.8%
% institutions6.5%
Last declaration on 24 November 2025
Declarations39 total
  • ●
    Executives
    3M DKK2DK FSA
    72 shares@ DKK 1.000.50% mcap0.8% of flowShareOutside a trading venueISIN DK0064642466DK:1402296
  • ●
    Executives
    26,804 DKK2DK FSA
    2 shares@ DKK 13,402.000.0045% mcap0.0% of flowShareOutside a trading venueISIN DK0063969092DK:1358283
  • ●
    BioPorto A/SExecutives
    628 DKK2DK FSA
    628 shares@ DKK 1.000.0001% mcap0.0% of flowShareNasdaq Copenhagen A/S, XCSEISIN DK0063068374DK:1303009
  • ●
    Related company / holdingExecutives
    0DK FSA
    0@ €0.4293ShareNasdaq Copenhagen A/S, XCSEISIN DK0011048619DK:1263924
  • ●
    Related company / holdingExecutives
    800M DKK19DK FSA
    8,000,000 shares@ DKK 100.00100.0% of flowShareNasdaq Copenhagen A/S, XCSEISIN DK0062496394DK:1235888
  • ●
    Executives
    2M DKK2DK FSA
    111,621 shares@ DKK 15.000.28% mcap0.4% of flowShareNasdaq Copenhagen A/S, XCSEISIN DK0061685906DK:1150863
  • ▼
    Executives
    23M DKK3DK FSA
    60,227 shares@ DKK 378.003.84% mcap5.8% of flowShareNasdaq Copenhagen A/S, XCSEDK:1034031
  • ▼
    Executives
    25M DKK3DK FSA
    40,000 shares@ DKK 614.004.14% mcap6.3% of flowShareNasdaq Copenhagen A/S, XCSEDK:1001300
  • ●
    Executives
    2M DKK2DK FSA
    111,621 shares@ DKK 16.000.30% mcap0.5% of flowShareNasdaq Copenhagen A/S, XCSEISIN DK0061409042DK:959153
  • ●
    Related company / holdingExecutives
    19M DKK2DK FSA
    116,707 shares@ DKK 160.003.14% mcap4.7% of flowShareNasdaq Copenhagen A/S, XCSEISIN DK0011048619DK:934471
  • ●
    Related company / holdingExecutives
    60M DKK13DK FSA
    150,000 shares@ DKK 397.0010.01% mcap15.1% of flowShareOutside a trading venueISIN DK0011048619DK:895526
  • ●
    Related company / holdingExecutives
    100M DKK14DK FSA
    254,453 shares@ DKK 393.0016.81% mcap25.4% of flowShareOutside a trading venueISIN DK0011048619DK:863196
  • ●
    Executives
    100M DKK5DK FSA
    312,500 shares@ DKK 320.0016.85% mcap25.4% of flowShareOutside a trading venueISIN DK0011048619DK:808670
  • ▲
    Executives
    31M DKK3DK FSA
    100,000 shares@ DKK 306.007.8% of flowShareOutside a trading venueISIN DK0011048619DK:786547
    Canonical exit: 8 Nov 2017 (T+90)
  • ▲
    Executives
    169,000 DKK2DK FSA
    100,000 shares@ DKK 1.690.0% of flowShareoutside a trading venueISIN DK0011048619DK:745848
    Canonical exit: 12 Feb 2017 (T+90)
  • ●
    Unknown
    Executives
    0DK FSA
    ShareDK:705282
  • ●
    Unknown
    Executives
    0DK FSA
    ShareDK:705009
  • ●
    Unknown
    Executives
    0DK FSA
    ShareDK:674482
  • ●
    Unknown
    Executives
    0DK FSA
    ShareDK:600799
  • ●
    Executives
    0DK FSA
    ShareISIN DK0011048619DK:572761
  • ●
    Executives
    0DK FSA
    ShareISIN DK0011048619DK:570338
  • ●
    Executives
    0DK FSA
    ShareISIN DK0011048619DK:569444
  • ●
    Executives
    0DK FSA
    ShareISIN DK0011048619DK:519037
  • ●
    Executives
    0DK FSA
    ShareISIN DK0011048619DK:447753
  • ●
    Executives
    0DK FSA
    ShareISIN DK0011048619DK:393305

25 of 39 declarations

About BioPorto A/S

BioPorto A/S is a Danish company specializing in the development of medical diagnostics. It focuses on innovative tests for serious diseases, particularly kidney disorders.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations